法国心力衰竭患者的医院资源利用和成本
Frank Chemouni1, Tiffany Chihiro Nishikawa2, Harinala Groyer3
1Grand Hôpital de l'Est Francilien, site de Marne-la-Vallée, 2-4 Cours de la Gondoire, 77600, Jossigny, France.
PharmacoEconomics - open
|September 15, 2023
概括
心力衰竭 (HF) 对法国医院造成重大负担,每年每名患者的费用为8341.3欧元. 诸如心脏不补偿,减少喷射率和并发症等因素增加了住院的频率,长度和成本.
科学领域:
- 心脏病学 心脏病学
- 卫生经济学 卫生经济学
- 公共卫生 公共卫生
背景情况:
- 心力衰竭 (HF) 是疾病和死亡的主要原因,对医疗保健系统造成重大经济压力.
- 了解医院资源利用率和HF患者的相关成本对于有效的医疗保健管理至关重要.
研究的目的:
- 估计目前法国心力衰竭患者的医院资源利用率和成本.
- 分析影响心力衰竭护理医院费用的因素.
主要方法:
- 在法国 (2019-2019) 住院的成年HF患者的回顾性队列研究.
- 从法国国家医院出院数据库中提取的数据,包括人口统计数据,住院时间,程序,"列表"项目和并发症.
- 按心脏衰减补偿,并发病,喷射率 (EF) 状态和患者类型 (事件/流行) 的分层.
主要成果:
- 2019年,法国有430544名患者因HF住院治疗,平均年龄为79.0岁.
- 对于HF,每年平均住院费用为每名患者8341.3欧元.
- 心脏失补偿,降低EF和并发症与更高的住院频率,持续时间和成本有关. 发生性HF患者在住院和设备上的成本较高,而流行性HF患者在创新药物的成本较高.
结论:
- 心力衰竭对法国医院来说是一个巨大的经济负担.
- 需要对各种高压患者资料进行进一步的研究,以确定医院成本的关键驱动因素.
- 这项研究强调了需要有针对性的策略来管理与高压相关的医疗保健支出.
更多相关视频
08:21Functional Assessment of the Donor Heart During Ex Situ Perfusion: Insights from Pressure-Volume Loops and Surface Echocardiography
Published on: October 11, 2022
2.1K
05:15Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
107
相关概念视频
01:30Heart Failure V: Medical Management
12
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
12
01:30Heart Failure VII: Nursing Interventions
90
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
90
01:22Heart Failure VI: Adjunct Therapies
16
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16
01:17Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
01:30Heart Failure IV: Classification and Diagnostic Evaluation
19
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
19
01:27Heart Failure I: Introduction
14
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
14